![Hero Primary](/my/sites/default/files/2024-02/Hero%20Primary_1.png)
Unlocking the Next
Chapter of Kidney Care
Meet the Expert Series: Video On Demand-Prof. Per Henrik Groop
There seems to be equivocal or no benefit in kidney disease progression in patients with A1, and A2 Albuminuria subgroups in EMPAKIDNEY. What's your point of view in these results?
Related Videos
Document ID: SC-ASK-00268